Cartesian Therapeutics, Inc.
6.79
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc., incorporated in Delaware, is a clinical-stage biopharmaceutical company pioneering RNA cell therapies for autoimmune diseases. Its lead asset, Descartes-08, is a potentially first-in-class RNA-engineered chimeric antigen receptor T cell therapy (rCAR-T) currently in Phase 2b clinical development for patients with systemic myasthenia gravis. The company also plans to initiate additional Phase 2 studies targeting systemic lupus erythematosus as well as autoimmune and vascular eye disorders within a basket trial framework. Cartesian operates a state-of-the-art, fully owned cGMP manufacturing facility located in Gaithersburg, Maryland. Company website: http://www.selectabio.com Address: 7495 New Horizon Way Frederick, MD 21703
Trade GPT
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.